Cancer Research UK logo.
SearchDonate
  • Search

This trial is looking at a drug called MK-2870 for cancer of the digestive system

Overview

Cancer types:

Bowel (colorectal) cancer, Pancreatic cancer, Secondary cancers

Status:

Open

Phase:

Phase 1/2

Details

This trial is looking at MK-2870 by itself or in combination with other drugs for some cancers of the .

It is open for people with the following cancers that have spread to another part of the body or cannot be removed by surgery:

  • bowel cancer

  • pancreatic cancer

  • bile duct cancer. The team have enough people in this group. It is now closed to recruitment.

  • gallbladder cancer. The team have enough people in this group. It is now closed to recruitment.

Bile duct cancer and gallbladder cancer are also called biliary tree cancers.

Recruitment start: 16 August 2024

Recruitment end: 24 July 2025

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Marco Gerlinger

Supported by

Merck Sharp & Dohme

Last reviewed: 20 May 2025

CRUK internal database number: 19935

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.